“…Because antipsychotic agents are known to stimulate prolactin secretion in both psychiatric patients (Copolov et al, 1990;Gruen et al, 1978;Keks, Copolov, & Singh, 1987;Markianos, Sakellariou, & Bistolaki, 1991) and normal controls (Hays & Rubin, 1981;Rubin & Hays, 1979;Rubin et al, 1976), prolactin response to haloperidol has been used to test the neuroendocrine responses to both acute (Copolov et al, 1990) and chronic (Kolakowska et al, 1991;Markianos et al, 1991) neuroleptic treatment. Because of the tonic inhibitory influence of DA on PRL secretion, neuroleptic blockade of DA activity results in a dosedependent increase in serum prolactin secretion, beginning about 20 min postinjection (Kolakowska et al, 1981;Rubin & Hays, 1979), presumably due to haloperidol's blockage of DA receptors on the pituitary lactotrophs (Carlsson, 1978).…”